Skip to content

Illumina ILMN Share Buybacks

Share Buybacks at other companies

Revvity logo
RevvityRVTY
$86.5M-43.7%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$7B
Guardant Health logo
Guardant HealthGH
$0-100%
Agilent Technologies logo
Agilent TechnologiesA
$65M-60.6%
Danaher logo
DanaherDHR
$894M
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$47.8M-53.1%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$29.2B+69.7%
Enterprise value$30.1B+63.8%
P/E35.4×+21.7×
P/S6.5×+2.5×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Illumina's share buybacks?
Illumina (ILMN) reported share buybacks of $242M in Q1 2026.
How has Illumina's share buybacks changed year-over-year?
Illumina's share buybacks increased by 21.0% year-over-year, from $200M to $242M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.